Welcome to our dedicated page for CADMF news (Ticker: CADMF), a resource for investors and traders seeking the latest updates and insights on CADMF stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect CADMF's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of CADMF's position in the market.
Chemesis International Inc. (OTC PINK:CADMF) announces the appointment of Terry White as Senior Vice President of Operations. White brings over 25 years of experience from the beverage sector, including a pivotal role at Coca-Cola. His expertise will focus on enhancing the VICKI program, an innovative AI-driven retail solution for cannabis. White aims to optimize logistics, improve consumer vending experiences, and implement industry best practices. Chemesis positions itself as a leader in the cannabis market with this strategic hire, catering to the burgeoning CBD market with advanced technology.
Chemesis International Inc. (CSE:CSI.U, OTC PINK:CADMF, FRA:CWAB) announced the upcoming change in its trading symbol on the Canadian Securities Exchange (CSE). As of February 25, 2021, the company’s common shares will commence trading in Canadian currency under the new symbol CSI. This strategic move aims to enhance market visibility and align better with Canadian investors. The CSE will publish a bulletin regarding this change.
Chemesis International Inc. (OTCQB: CADMF) has partnered with The Pelican Group to deploy CBD vending machines across the nation. Pelican, with nearly five decades in the vending industry, will manage the program and collaborate with selected operators. The initiative aims to enhance revenue potential for operators. Chemesis is also allocating US $1,318,943 for marketing services through CDMG Inc. to boost investor awareness. The company continues to focus on its AI-driven retail solutions and expanding its presence in the cannabis market.
Chemesis International Inc. (OTCQB: CADMF) has partnered with RESET & Produce Portland to launch its AI retail solution in Portland, Oregon. This collaboration marks the initial step in expanding Chemesis' CBD experience across various markets. The deployment of the VICKI AI retail solution is expected in the coming weeks, featuring popular CBD brands. This non-traditional market placement aims to gather valuable insights on millennial and Gen Z consumers, aiding Chemesis in refining its sales strategies. Chemesis is focused on enhancing its brand presence in the cannabis sector.
Chemesis International Inc. (CSE:CSI)(OTCQB:CADMF) has announced the sale of its cannabis assets in Puerto Rico through its subsidiaries, Natural Ventures PR, LLC and GSRX Industries Inc., to Puerto Rico Industrial Commercial Holdings Biotech Corp. (PRICH). Chemesis will receive US$450,000 for its 80% stake in NVPR and US$2,250,000 from GSRX, alongside monthly payments of US$100,000 over two years. As a result, the Company will no longer hold any shares in NVPR.
Chemesis International Inc. has launched its VICKI Artificial Intelligence Self-Checkout Solutions at Atlanta International Airport, collaborating with Business Traveler Services, Inc. The deployment includes branded CBD automated retail stores under Green Spirit Rx. VICKI enhances consumer engagement through advanced technology, allowing for convenient on-the-go transactions. The project serves as a proof of concept for expanding this retail model across various high-traffic locations. Chemesis aims to leverage its technology and partnerships to capture a significant share of the expanding CBD market.
Chemesis International Inc. (CSE:CSI)(OTCQB:CADMF) announced a 60-day extension for its Puerto Rico cannabis licenses held by Natural Ventures PR LLC, granted by the Department of Health. This routine extension occurs every two months during the ongoing appeal process regarding the licenses. The company assures that operations under the licenses continue normally. Caution is advised regarding forward-looking statements that may not guarantee future results or profitability.